IT1255199B - Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani - Google Patents

Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani

Info

Publication number
IT1255199B
IT1255199B ITMI921612A ITMI921612A IT1255199B IT 1255199 B IT1255199 B IT 1255199B IT MI921612 A ITMI921612 A IT MI921612A IT MI921612 A ITMI921612 A IT MI921612A IT 1255199 B IT1255199 B IT 1255199B
Authority
IT
Italy
Prior art keywords
melatonin
particularly effective
interfer
pathologies
circadian rhythms
Prior art date
Application number
ITMI921612A
Other languages
English (en)
Inventor
Franco Fraschini
Aldo Laguzzi
Original Assignee
Franco Fraschini
Aldo Laguzzi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11363605&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1255199(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Franco Fraschini, Aldo Laguzzi filed Critical Franco Fraschini
Priority to ITMI921612A priority Critical patent/IT1255199B/it
Publication of ITMI921612A0 publication Critical patent/ITMI921612A0/it
Priority to EP93830269A priority patent/EP0585206B1/en
Priority to AT93830269T priority patent/ATE187442T1/de
Priority to DE69327207T priority patent/DE69327207D1/de
Priority to JP5159817A priority patent/JP2805575B2/ja
Publication of ITMI921612A1 publication Critical patent/ITMI921612A1/it
Priority to US08/196,380 priority patent/US5552428A/en
Application granted granted Critical
Publication of IT1255199B publication Critical patent/IT1255199B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmaco sintetizzato analogo della melatonina particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani
ITMI921612A 1992-06-24 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani IT1255199B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI921612A IT1255199B (it) 1992-07-01 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
EP93830269A EP0585206B1 (en) 1992-07-01 1993-06-24 Tryptamines for treatment of circadian rhythm disorders
AT93830269T ATE187442T1 (de) 1992-07-01 1993-06-24 Tryptamine zur behandlung von störungen der circadianen rhythmik
DE69327207T DE69327207D1 (de) 1992-07-01 1993-06-24 Tryptamine zur Behandlung von Störungen der circadianen Rhythmik
JP5159817A JP2805575B2 (ja) 1992-07-01 1993-06-30 概日リズム治療用薬剤、これに用いる化合物およびその合成方法
US08/196,380 US5552428A (en) 1992-06-24 1994-02-15 Compounds effective in the treatment of circadian rhythms and related disorders, the novel pharmaceutical preparations and novel method of application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921612A IT1255199B (it) 1992-07-01 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani

Publications (3)

Publication Number Publication Date
ITMI921612A0 ITMI921612A0 (it) 1992-07-01
ITMI921612A1 ITMI921612A1 (it) 1994-01-01
IT1255199B true IT1255199B (it) 1995-10-20

Family

ID=11363605

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921612A IT1255199B (it) 1992-06-24 1992-07-01 Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani

Country Status (5)

Country Link
EP (1) EP0585206B1 (it)
JP (1) JP2805575B2 (it)
AT (1) ATE187442T1 (it)
DE (1) DE69327207D1 (it)
IT (1) IT1255199B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180657B1 (en) * 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
EP0753147A1 (en) 1994-03-30 1997-01-15 Novartis AG Screening method using the rzr receptor family
FR2737725B1 (fr) * 1995-08-08 1997-10-31 Valentonine Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament
WO1999023070A1 (en) * 1997-11-04 1999-05-14 St. Elizabeth's Medical Center Of Boston, Inc. N-acetylserotonin derivatives and uses thereof
US8053462B2 (en) 2004-03-08 2011-11-08 Masanori Somei Indole derivative and application thereof
JP3964417B2 (ja) 2004-09-27 2007-08-22 国立大学法人金沢大学 インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
IL301026A (en) * 2020-09-01 2023-05-01 Enveric Biosciences Canada Inc Halogenated psilocybin derivatives and methods of using
CN113480467B (zh) * 2021-07-13 2022-12-30 河北维达康生物科技有限公司 一种放射性示踪剂2-碘褪黑素的合成工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126630B1 (en) * 1983-05-18 1987-09-16 Monash University The use of melatonin for the manufacture of a medicament
AU616907B2 (en) * 1987-08-17 1991-11-14 Whitby Research, Inc. Melatonin analogues
DE69115221T2 (de) * 1990-09-28 1996-08-22 I F L O S A S Di Giorgio E Ald Methode zur Synthese eines Präparats zur Regulation der Empfängnis und des Menstruationszyklus mit onkostatischen antikinetosischen, preventiven und therapeutischen Eigenschaften zur Behandlung von Brustkrebs und Melanomen.
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
JPH06183968A (ja) 1994-07-05
ATE187442T1 (de) 1999-12-15
JP2805575B2 (ja) 1998-09-30
ITMI921612A1 (it) 1994-01-01
EP0585206A1 (en) 1994-03-02
ITMI921612A0 (it) 1992-07-01
DE69327207D1 (de) 2000-01-13
EP0585206B1 (en) 1999-12-08

Similar Documents

Publication Publication Date Title
PT851855E (pt) Derivados acilados de melatonina e de analogos uteis como medicamentos
FI943625A0 (fi) Menetelmiä tulehduksellisten ihotautien hoitamiseksi
DE69034018D1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
ATE164593T1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
IT1255199B (it) Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
JPS5484546A (en) Substituted amide derivative of ll* dllphenylglycine*its manufacture and therapeutic medicine thereof
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
IT7849358A0 (it) Procedimento per la cura farmacologica dell'abitudine alla droga con alfa-metil-para-tirosina
IT1203934B (it) Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata
NO171679C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(1-piperazinyl)-1h-indazoler
ITMI921556A1 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
IT8312019A0 (it) Mezzo di autotrattamento elettroterapeutico del dolore e dell'insonnia ad associazione di campi
IT7850228A0 (it) Composti eterociclici della serie dell'indolo con impiego farmaceutico e procedimento per la loro produzione
GB8823297D0 (en) Wall-mounted luminaire for treatment of seasonal affective disorder
IT7820500A0 (it) Prieta' analgesiche, antinfiammatocomposizioni farmaceutiche con prorie e inibitrici della sintetasi di prostaglandina
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
IT1142590B (it) Procedimento per la produzione di ormone umano della crescita
ITMI910381A1 (it) Medicamento per il trattamento della dermatite
IT9021768A0 (it) Derivato della melatonina ad attivita' terapeutica in dermatologia
NO168357C (no) Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfider
IT8848208A0 (it) Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria
NO168473C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.
NO172576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-(fluoralkylen)-5-hydroxytryptofan-derivater
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960623